159 related articles for article (PubMed ID: 33305798)
1. Heterozygous deletion of Sox9 in mouse mimics the gonadal sex reversal phenotype associated with campomelic dysplasia in humans.
Bagheri-Fam S; Combes AN; Ling CK; Wilhelm D
Hum Mol Genet; 2021 Feb; 29(23):3781-3792. PubMed ID: 33305798
[TBL] [Abstract][Full Text] [Related]
2. The conditional deletion of steroidogenic factor 1 (Nr5a1) in Sox9-Cre mice compromises testis differentiation.
Ikeda Y; Tagami A; Maekawa M; Nagai A
Sci Rep; 2021 Feb; 11(1):4486. PubMed ID: 33627800
[TBL] [Abstract][Full Text] [Related]
3. The regulation of Sox9 gene expression by the GATA4/FOG2 transcriptional complex in dominant XX sex reversal mouse models.
Manuylov NL; Fujiwara Y; Adameyko II; Poulat F; Tevosian SG
Dev Biol; 2007 Jul; 307(2):356-67. PubMed ID: 17540364
[TBL] [Abstract][Full Text] [Related]
4.
Richardson N; Gillot I; Gregoire EP; Youssef SA; de Rooij D; de Bruin A; De Cian MC; Chaboissier MC
Elife; 2020 May; 9():. PubMed ID: 32450947
[TBL] [Abstract][Full Text] [Related]
5. Sox9 in testis determination.
Kobayashi A; Chang H; Chaboissier MC; Schedl A; Behringer RR
Ann N Y Acad Sci; 2005 Dec; 1061():9-17. PubMed ID: 16467253
[TBL] [Abstract][Full Text] [Related]
6. Correct dosage of Fog2 and Gata4 transcription factors is critical for fetal testis development in mice.
Bouma GJ; Washburn LL; Albrecht KH; Eicher EM
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):14994-9. PubMed ID: 17848526
[TBL] [Abstract][Full Text] [Related]
7. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9).
Ludbrook LM; Bernard P; Bagheri-Fam S; Ryan J; Sekido R; Wilhelm D; Lovell-Badge R; Harley VR
Endocrinology; 2012 Apr; 153(4):1948-58. PubMed ID: 22294746
[TBL] [Abstract][Full Text] [Related]
8. Inefficient Sox9 upregulation and absence of Rspo1 repression lead to sex reversal in the B6.XYTIR mouse gonad†.
Cao J; El Mansouri F; Reynoso S; Liu Z; Zhu J; Taketo T
Biol Reprod; 2024 May; 110(5):985-999. PubMed ID: 38376238
[TBL] [Abstract][Full Text] [Related]
9. Gonadal Identity in the Absence of Pro-Testis Factor SOX9 and Pro-Ovary Factor Beta-Catenin in Mice.
Nicol B; Yao HH
Biol Reprod; 2015 Aug; 93(2):35. PubMed ID: 26108792
[TBL] [Abstract][Full Text] [Related]
10. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice.
Barrionuevo F; Bagheri-Fam S; Klattig J; Kist R; Taketo MM; Englert C; Scherer G
Biol Reprod; 2006 Jan; 74(1):195-201. PubMed ID: 16207837
[TBL] [Abstract][Full Text] [Related]
11. A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal.
Cameron FJ; Hageman RM; Cooke-Yarborough C; Kwok C; Goodwin LL; Sillence DO; Sinclair AH
Hum Mol Genet; 1996 Oct; 5(10):1625-30. PubMed ID: 8894698
[TBL] [Abstract][Full Text] [Related]
12. XY Sox9 embryonic loss-of-function mouse mutants show complete sex reversal and produce partially fertile XY oocytes.
Lavery R; Lardenois A; Ranc-Jianmotamedi F; Pauper E; Gregoire EP; Vigier C; Moreilhon C; Primig M; Chaboissier MC
Dev Biol; 2011 Jun; 354(1):111-22. PubMed ID: 21466799
[TBL] [Abstract][Full Text] [Related]
13. Evidence to exclude SOX9 as a candidate gene for XY sex reversal without skeletal malformation.
Kwok C; Goodfellow PN; Hawkins JR
J Med Genet; 1996 Sep; 33(9):800-1. PubMed ID: 8880588
[TBL] [Abstract][Full Text] [Related]
14. Familial 46,XY sex reversal without campomelic dysplasia caused by a deletion upstream of the SOX9 gene.
Bhagavath B; Layman LC; Ullmann R; Shen Y; Ha K; Rehman K; Looney S; McDonough PG; Kim HG; Carr BR
Mol Cell Endocrinol; 2014 Aug; 393(1-2):1-7. PubMed ID: 24907458
[TBL] [Abstract][Full Text] [Related]
15. Loss of Fgfr2 leads to partial XY sex reversal.
Bagheri-Fam S; Sim H; Bernard P; Jayakody I; Taketo MM; Scherer G; Harley VR
Dev Biol; 2008 Feb; 314(1):71-83. PubMed ID: 18155190
[TBL] [Abstract][Full Text] [Related]
16. Expression of AMH, SF1, and SOX9 in gonads of genetic female chickens during sex reversal induced by an aromatase inhibitor.
Vaillant S; Magre S; Dorizzi M; Pieau C; Richard-Mercier N
Dev Dyn; 2001 Oct; 222(2):228-37. PubMed ID: 11668600
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous SOX9 mutations allowing for residual DNA-binding and transcriptional activation lead to the acampomelic variant of campomelic dysplasia.
Staffler A; Hammel M; Wahlbuhl M; Bidlingmaier C; Flemmer AW; Pagel P; Nicolai T; Wegner M; Holzinger A
Hum Mutat; 2010 Jun; 31(6):E1436-44. PubMed ID: 20513132
[TBL] [Abstract][Full Text] [Related]
18. Mouse Gonad Development in the Absence of the Pro-Ovary Factor WNT4 and the Pro-Testis Factor SOX9.
Tang F; Richardson N; Albina A; Chaboissier MC; Perea-Gomez A
Cells; 2020 Apr; 9(5):. PubMed ID: 32365547
[TBL] [Abstract][Full Text] [Related]
19. Normal Levels of Sox9 Expression in the Developing Mouse Testis Depend on the TES/TESCO Enhancer, but This Does Not Act Alone.
Gonen N; Quinn A; O'Neill HC; Koopman P; Lovell-Badge R
PLoS Genet; 2017 Jan; 13(1):e1006520. PubMed ID: 28045957
[TBL] [Abstract][Full Text] [Related]
20. Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development.
Kim GJ; Sock E; Buchberger A; Just W; Denzer F; Hoepffner W; German J; Cole T; Mann J; Seguin JH; Zipf W; Costigan C; Schmiady H; Rostásy M; Kramer M; Kaltenbach S; Rösler B; Georg I; Troppmann E; Teichmann AC; Salfelder A; Widholz SA; Wieacker P; Hiort O; Camerino G; Radi O; Wegner M; Arnold HH; Scherer G
J Med Genet; 2015 Apr; 52(4):240-7. PubMed ID: 25604083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
